Immuron (IMRN) Return on Sales (2016 - 2024)
Immuron (IMRN) recorded quarterly Return on Sales of 0.01% in Q4 2024, up 27.78% quarter-over-quarter from 0.01% in Q4 2023, and little changed on a YoY basis from 0.01% in Q1 2024.
Immuron (IMRN) Return on Sales (2016 - 2024) Analysis & Trends
Immuron's Return on Sales history runs 9 years deep, the most recent figure standing at 0.01% for Q4 2024.
- In Q4 2024, Return on Sales changed 0.0% year-over-year to 0.01%; the TTM figure through Dec 2024 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
- Return on Sales was 0.01% for Q4 2024 at Immuron, up from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2022 to a low of 38659.11% in Q4 2020.
- Historically, Return on Sales has averaged 6443.22% across 5 years, with a median of 0.04% in 2021.
- The sharpest annual moves came in 2020 and 2021: Return on Sales slumped 3865910 bps in 2020, then jumped 3865903 bps in 2021.
- A 5-year view of Return on Sales shows it stood at 38659.11% in 2020, then soared by 100 bps to 0.08% in 2021, then surged by 100 bps to 0.0% in 2022, then plunged by 3852 bps to 0.01% in 2023, then increased by 28 bps to 0.01% in 2024.
- The last three Return on Sales figures came in at 0.01% (Q4 2024), 0.01% (Q4 2023), and 0.15% (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Jun 30, 2023 | -0.15% |
| Dec 31, 2022 | 0.00% |
| Dec 31, 2021 | -0.08% |
| Dec 31, 2020 | -38,659.11% |
| Dec 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.02% |
| Dec 31, 2017 | 0.05% |
| Dec 31, 2016 | 0.05% |
| Jun 30, 2016 | -0.04% |